Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.
about
A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary HypertensionPulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular functionSex differences in the pulmonary circulation: implications for pulmonary hypertensionThe right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertensionIdentifying "super responders" in pulmonary arterial hypertension.Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsValidation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials.Sex differences in response to tadalafil in pulmonary arterial hypertension.Sex and haemodynamics in pulmonary arterial hypertension.Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.BMPR2 expression is suppressed by signaling through the estrogen receptor.Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.Update in Pulmonary Vascular Diseases 2014.Severity of systemic sclerosis-associated pulmonary arterial hypertension in African AmericansSex and menopause differences in response to tadalafil: 6-minute walk distance and time to clinical worsening.The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study.Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.The relationships between lifestyle factors and hypertension in community-dwelling Korean adultsEndothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial HypertensionToward Precision Medicine in Pulmonary Arterial HypertensionEndothelin, sex, and pregnancy: unique considerations for blood pressure control in females.Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcomeAdverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Gender, sex hormones and pulmonary hypertension.A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.Progress in solving the sex hormone paradox in pulmonary hypertension.Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Racial and ethnic differences in pulmonary arterial hypertension.Melatonin as a preventive and curative therapy against pulmonary hypertension.17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension.Pulmonary Arterial Hypertension in Women.
P2860
Q27026643-E87772BE-290C-4ED7-A262-209EC20A9B35Q28117980-399E16DA-EB4B-496B-8365-99959547B833Q30241478-4F154B34-E54B-4777-A9B2-7EE7FC625548Q30277940-D4B4FAB5-1C8F-45E8-8C3C-61356A20B351Q33568826-8A50AC6C-F301-4CDB-8BA8-DFD375DD1317Q33702614-66D46AB9-A656-4C9F-8079-00220CE6BDFEQ33788452-5067F458-4398-40BD-A3C1-5E5614024180Q34344390-2B49E31D-6AAC-42F3-8F34-43DE7C8B8523Q34541733-99A109B8-B4C3-49DC-BB2D-8BC657679907Q34840330-2F1C7D89-12F7-410A-AE1E-DDB4D8E73CA5Q35116055-84C007FC-3ACA-4906-BD9E-AAED821DB2A1Q35574717-4DF71708-6094-4011-B74D-3883FCD06D41Q35848094-D47C01C8-073B-4678-90BF-5932EA04A2BDQ36120117-6CA4CE1E-C429-45A8-AD3B-FF46BDA6BDC2Q36128639-46DC17C5-DAD8-41BA-984D-16D550641010Q36150934-87987936-8D61-4E1F-8CFD-CB8C2203FD7AQ36352106-185C4E91-7174-4924-AD71-C0FCFB46FFD3Q36366106-82A22B55-857D-434B-A6CF-71DA473469E3Q36411409-F2CC0117-CC31-4BB5-A3B6-88458EF9C442Q36465209-4431027B-FC84-46FA-A28C-31405325A5B6Q36516814-2E806809-6308-42D9-8DD2-E6B069648924Q36516839-4061B1F0-B13B-4FDE-9433-8AD0CFAE43C5Q36902613-D8D1D6F0-8E8F-48ED-B872-E6211DF2FFF7Q36951990-774204E0-45F2-484B-A8E4-6C67ED697DA4Q37106203-594CE0AA-CD24-4F7C-A212-D153DEF37483Q37133789-3D70785D-F7D3-4838-85D4-616BB65DD945Q37152779-241A1D13-4D56-4C10-80BB-C673C6763D55Q37671277-EAA1A2D7-E2B8-492A-AFA5-ADB883CA7AF9Q37671280-A084F8B0-8691-4E82-882D-884B2AE72F25Q38210880-0B59CDD1-380C-4EEE-90EF-CD646C62A8F3Q38403596-1A224159-124C-4240-B6A2-6B6A2CC98E1EQ40066822-A32001B4-0383-491D-BDF3-4DF138155C85Q40708102-D8E64D07-A5F0-4BB1-A606-D5607C1AAD89Q42356930-DC132F72-21D1-400C-B7E2-47A9DE6E5E6CQ45325795-1AC7593B-C003-41C9-85AA-323598393047Q50021216-AD333518-D812-4342-85E8-05F78E69D69AQ53702217-E5B762D0-24F5-4667-9894-40F973BAD0CEQ55408049-6AEDF0C0-D832-48F9-A762-7D38EF51181B
P2860
Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Race and sex differences in re ...... lmonary arterial hypertension.
@en
Race and sex differences in re ...... lmonary arterial hypertension.
@nl
type
label
Race and sex differences in re ...... lmonary arterial hypertension.
@en
Race and sex differences in re ...... lmonary arterial hypertension.
@nl
prefLabel
Race and sex differences in re ...... lmonary arterial hypertension.
@en
Race and sex differences in re ...... lmonary arterial hypertension.
@nl
P2093
P2860
P356
P1433
P1476
Race and sex differences in re ...... lmonary arterial hypertension.
@en
P2093
Benjamin French
Brian L Strom
Harold I Palevsky
Nicole B Gabler
Scott D Halpern
Steven M Kawut
P2860
P356
10.1378/CHEST.11-0404
P407
P577
2011-09-22T00:00:00Z